It should be emphasized that DC/IL-18 + IL-12/TAg cells showed the greatest ability to infiltrate tumor tissue already on the 3rd day after administration, and then, their number during the following days of observation diminished more slowly than in other groups (Figures 2(c) and 2(e)). The gene discussed is IL18; the disease is neoplasm.